# Aurinia Pharmaceuticals Inc.: Form 8-K, filed Aug 21, 2023

- Company: [Aurinia Pharmaceuticals Inc.](/companies/auph.md) (CIK 1600620)
- Form: 8-K
- Filed: 2023-08-21
- Accepted by EDGAR: Aug 21, 2023, 16:11 ET
- Period: 2023-08-18
- Accession: 0001600620-23-000030
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000030/auph-20230818.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1600620/000160062023000030/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1600620/000160062023000030/auph-20230818.htm

Filed Aug 21, 2023.
Source: SEC EDGAR, the filing index for accession 0001600620-23-000030. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.